Anyone can contribute to The Roar and have their work featured alongside some of Australia’s most prominent sports journalists. Queensland will hunt a vital Sheffield Shield win at the Gabba aft ...
Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...